Taqman-MGB method for determining CYP3A5 rs776746 site SNP and the influence of this site on the metabolism of tacrolimus

Lilan JIN,Gang CAI,Lin LIN,Xianghui WANG

DOI: https://doi.org/10.3969/j.issn.1673-8640.2015.08.014

IF: 1.865

2015-01-01

Laboratory Medicine

Abstract:Objective To establish Taqman-MGB real-time fluorescence polymerase chain reaction ( PCR ) for determining CYP3A5 rs776746 site single nucleotide polymorphism ( SNP), and to analyze the influence on the metabolism of tacrolimus.Methods The primers and double-labeled probes were designed according to the genotype of CYP3A5 rs776746 site, and the Taqman-MGB real-time fluorescence PCR for SNP was established and evaluated.A total of 170 whole blood DNA samples from patients who took tacrolimus were collected, and CYP3A5 genotype was determined by Taqman-MGB real-time fluorescence PCR.The relationship between CYP3A5 genotype and tacrolimus concentration to dose ratio was analyzed.Results The established Taqman-MGB method can discriminate CYP3A5 rs776746 site efficiently with good reproducibility and specificity and had a detection limit of 0.01 ng for DNA.The results of Taqman-MGB method were consistent with those of sequencing.Among the 170 samples, 18 samples belonged to CYP3A5*1/*1(10.59%), 65 samples were CYP3A5*1/*3(38.24%) and 87 samples were CYP3A5*3/*3 (51.18%).Among the samples collected, 104 samples belonged to renal allograft recipients, and the mean tacrolimus concentrations to dose ratios for 3 genotypes were (52.47 ±35.96), (77.79 ±33.80) and (134.80 ±79.35) (ng/mL)/(mg· kg-1· d-1), and there was statistical significance (P<0.05).Conclusions The Taqman-MGB method for determining CYP3A5 rs776746 site SNP is established, which has high sensitivity, specificity and reproducibility and is a rapid method for clinical practice.Through primary analysis, the existence of CYP3A5*3 genotype do weaken the ability of metabolizing tacrolimus.